Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Mr. Olivier Loeillot is the President of Repligen Corp, joining the firm since 2023.
What is the price performance of RGEN stock?
The current price of RGEN is $126.57, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Repligen Corp?
Repligen Corp belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Repligen Corp market cap?
Repligen Corp's current market cap is $7.1B
Is Repligen Corp a buy, sell, or hold?
According to wall street analysts, 22 analysts have made analyst ratings for Repligen Corp, including 7 strong buy, 15 buy, 6 hold, 0 sell, and 7 strong sell